Masayuki Kobayashi

Chiba Cancer Center

Papers

1

Total Citations

3

H-Index

1

About

Masayuki Kobayashi is a urologic oncologist whose research focuses on optimizing surgical outcomes for high-risk prostate cancer, particularly clinical T3 disease. His most cited work, a 2018 study analyzing 1,409 radical prostatectomy patients, identified key factors predicting biochemical recurrence in men with locally advanced prostate cancer. By demonstrating that cancer control outcomes can be favorable in carefully selected cT3 patients, Kobayashi challenged prevailing assumptions about the limited role of surgery in this population. His findings have informed risk stratification and treatment decision-making, contributing to a growing body of evidence supporting radical prostatectomy as a viable option for select high-risk cases. While his citation count remains modest, Kobayashi’s work addresses a critical gap in urologic oncology, bridging surgical technique with prognostic modeling. His research underscores the importance of patient selection and pathological variables in achieving durable cancer control, offering practical guidance for clinicians managing complex prostate cancer cases.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Factors predicting biochemical recurrence after radical prostatectomy among patients with clinical T3 prostate cancer
3 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Chiba Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago